Insulin aspart Clinical Trials
6 recruitingDrug
Not Applicable2Early Phase 12Phase 21Phase 31
Showing 1–6 of 6 trials
Recruiting
Phase 3
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes
Diabetes Mellitus, Type 1
Novo Nordisk A/S877 enrolled193 locationsNCT07076199
Recruiting
Early Phase 1
Role of ET-1, Physical Activity, and Sedentary Behavior in Microvascular Dysfunction Following GDM
Physical InactivityEndothelial DysfunctionGestational Diabetes
Anna Stanhewicz, PhD40 enrolled1 locationNCT06547619
Recruiting
Early Phase 1
Role of NADPH Oxidase in Microvascular Dysfunction Following GDM
Gestational DiabetesOxidative StressVascular Endothelial Function
Anna Stanhewicz, PhD40 enrolled1 locationNCT05946798
Recruiting
Not Applicable
Comparing the Efficacy and Safety Between Continuous Subcutaneous Beinaglutide and CSII for Newly Diagnosed T2DM Patients
T2DMT2DM (Type 2 Diabetes Mellitus)Type 2 Diabetic Patients
Beijing Hospital115 enrolled16 locationsNCT03987308
Recruiting
Phase 2
A Trial Comparing Efficacy, Tolerability, and Safety of GZR101 Injection Once Daily (OD) and GZR33-70 Injection OD
Type 2 Diabetes
Gan and Lee Pharmaceuticals, USA60 enrolled1 locationNCT06558708
Recruiting
Not Applicable
Pilot Study Evaluating Safety of ExOlin® in Patients With Poorly Controlled Type 1 Diabetes
Type 1 DiabetesType 1 Diabetes Mellitus With Hypoglycemia
Defymed8 enrolled1 locationNCT05221359